White Paper Takes Deeper Dive on Role of Single-use Bronchoscopes
As it turns out, Dr. Murgu indicates that coronaviruses are easy to kill with high-level disinfectants or sterilization cycles as part of standard reprocessing practices. In the paper, he explains the hierarchy of microorganisms and their susceptibility to high-level disinfection. “It is noteworthy to recognize that the transmission and pathogenicity of microorganisms do not equate to their susceptibility to disinfectants,” he writes. Thus, the move to SUFBs should not be based on the “highly transmissible” argument, provided existing reprocessing protocols are followed.
Weighing risks and benefits
Dr. Murgu looks at the purported benefits of SUFBs—portability, cost, and time efficiency—to fill in the urgent care gap, citing survey data and literature worth a closer review in determining SUFBs true utility. This is weighed against the limited technology he discusses in the paper and less advanced imaging capabilities of SUFBs. Nonetheless, “each offers advantages in specific procedural settings.”
Dr. Murgu is a paid consultant to Olympus Corporation of the Americas, which underwrote the production costs for this white paper.
All quotes taken directly from featured white paper, Evaluating Reusable Versus Single-use Bronchoscopes: A perspective on their unique roles in ICUs, ORs, and bronchoscopy suites during COVID-19 and beyond (2021) by Dr. Septimiu Dan Murgu.